228. Bronchiolitis obliterans Clinical trials / Disease details
Clinical trials : 97 / Drugs : 118 - (DrugBank : 32) / Drug target genes : 33 - Drug target pathways : 156
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00367419 (ClinicalTrials.gov) | November 2006 | 21/8/2006 | Use of Erythromycin in Mustard-Induced Bronchiolitis | Low-Dose Long-Term Prescription of Erythromycin in Mustard-Induced Bronchiolitis Obliterans | Bronchiolitis Obliterans;Acute Obliterating Bronchiolitis | Drug: Erythromycin | Baqiyatallah Medical Sciences University | NULL | Completed | N/A | N/A | Male | Phase 4 | Iran, Islamic Republic of |